drug

ADX-097

1 story · latest Aug 5, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Akebia Therapeutics

Timeline

Akebia reports Q2 2026 results, VOICE interim data, and new ebribafusp trial

Aug 5Quarterly updateAkebia Therapeutics vadadustat

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.